Antibiotic Coated Nail for Preventing Infection in Broken Bones
Trial Summary
What is the purpose of this trial?
This prospective randomized clinical trial will compare outcomes between patients treated primarily with a prophylactic antibiotic coated nail and those treated with traditional standard of care intramedullary (IM) nailing.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Antibiotic Coated Nail for preventing infection in broken bones?
Research shows that antibiotic-coated nails are effective in treating bone infections, especially in cases where the bone is not healing properly. They release high levels of antibiotics directly at the site, helping to control infection and support bone healing, with studies reporting a high success rate in infection control and bone healing.12345
How is the antibiotic-coated intramedullary nail treatment different from other treatments for preventing infections in broken bones?
The antibiotic-coated intramedullary nail is unique because it releases high concentrations of antibiotics directly at the site of the fracture, providing both infection control and bone stability, which is not typically achieved with standard treatments. This local delivery minimizes systemic side effects and enhances the healing process in cases of infected fractures or non-unions.12345
Research Team
Joseph Hsu, MD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for adults with a type II or III open tibia fracture needing a nail implant to fix the bone. Participants must be able to follow up for a year and speak English or Spanish. It's not for those under 18, allergic to vancomycin/gentamicin, pregnant/lactating women, prisoners, or unable to commit.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a prophylactic antibiotic coated intramedullary nail or a traditional standard of care intramedullary nail during definitive fixation
Follow-up
Participants are monitored for safety and effectiveness after treatment, with data capture at baseline, 6 weeks, 3 months, 6 months, and 12 months
Treatment Details
Interventions
- Antibiotic coated intramedullary Nail
- Standard Intramedullary Nail
Antibiotic coated intramedullary Nail is already approved in India for the following indications:
- Infected nonunion and chronic osteomyelitis of long bones
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor